MARKET

SENS

SENS

Senseonics
AMEX

Real-time Quotes | Nasdaq Last Sale

1.130
+0.010
+0.89%
Pre Market: 1.160 +0.03 +2.65% 06:17 05/27 EDT
OPEN
1.100
PREV CLOSE
1.120
HIGH
1.160
LOW
1.100
VOLUME
540
TURNOVER
--
52 WEEK HIGH
4.580
52 WEEK LOW
0.7701
MARKET CAP
523.49M
P/E (TTM)
29.97
1D
5D
1M
3M
1Y
5Y
Senseonics to Participate in the Jefferies Healthcare Conference
GERMANTOWN, Md., May 26, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today ...
Business Wire · 20h ago
Senseonics to Participate in the H.C. Wainwright Global Investment Conference
GERMANTOWN, Md., May 16, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today ...
Business Wire · 05/16 20:05
Cullinan Oncology, Concert Pharmaceuticals top healthcare gainers; Eargo, Senseonics lead losers' pack
Gainers: Cullinan Oncology (CGEM) +21%. Concert Pharmaceuticals (CNCE) +20%. Babylon Holdings (BBLN) +16%. Blue Water Vaccines (BWV) +14%.  ViewRay (VRAY) +10%. Losers: Eargo (EAR) -24%. Senseonics (SENS) -14%. Ascendis Pharma (ASND) -11%. Evaxion Biotech ...
Seekingalpha · 05/12 14:00
52 Stocks Moving In Wednesday's Mid-Day Session
Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247 million.
Benzinga · 05/11 16:25
Senseonics Holdings: Q1 Earnings Insights
Senseonics Holdings (AMEX:SENS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Senseonics Holdings reported in-line EPS of $-0.03 versus an estimate of $-0.03.
Benzinga · 05/10 22:23
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates
Senseonics (SENS) delivered earnings and revenue surprises of 0% and 16.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/10 22:15
-- Earnings Flash (SENS) SENSEONICS HOLDINGS Reports Q1 Revenue $2.5M, vs. Street Est of $2.24M
MT Newswires · 05/10 16:31
Earnings Scheduled For May 10, 2022
  Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
Benzinga · 05/10 09:18
More
No Data
Learn about the latest financial forecast of SENS. Analyze the recent business situations of Senseonics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

20.00%Strong Buy
20.00%Buy
20.00%Hold
40.00%Under-perform
0.00%Sell
Analyst Price Target
The average SENS stock price target is 3.100 with a high estimate of 6.00 and a low estimate of 0.8000.
High6.00
Average3.100
Low0.8000
Current 1.168
EPS
Actual
Estimate
-0.28-0.15-0.010.13
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 117
Institutional Holdings: 93.52M
% Owned: 20.19%
Shares Outstanding: 463.26M
TypeInstitutionsShares
Increased
49
4.74M
New
13
3.28M
Decreased
18
5.37M
Sold Out
21
1.58M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.39%
Healthcare Equipment & Supplies
+2.33%
Key Executives
Non-Executive Chairman/Independent Director
Stephen DeFalco
President/Chief Executive Officer/Director
Timothy Goodnow
Chief Financial Officer/Treasurer/Secretary
Nick Tressler
Chief Operating Officer
Mukul Jain
General Counsel
Kenneth Horton
Other/Director
Francine Kaufman
Director
John Marotta
Director
Robert Schumm
Independent Director
Steven Edelman
Independent Director
Edward Fiorentino
Independent Director
Sharon Larkin
Independent Director
Douglas Prince
Independent Director
Anthony Raab
Independent Director
Douglas Roeder
No Data
No Data
About SENS
Senseonics Holdings, Inc. is a medical technology company. The Company is focused on the development and commercialization of continuous glucose monitoring (CGM) system. Its Eversense and Eversense XL CGM systems are designed to measure glucose levels in people with diabetes via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an application for real-time diabetes monitoring and management for a period of up to 90 and 180 days, as compared to seven to 14 days for non-implantable CGM systems. Its Eversense system consists of three primary components, such as a sensor, inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user's mobile device.

Webull offers kinds of Senseonics Holdings Inc stock information, including AMEX:SENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SENS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SENS stock methods without spending real money on the virtual paper trading platform.